 | • レポートコード：QAF27627 • 出版社/出版日：QYResearch / 2021年4月6日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のコロイド（血漿）市場について種類別（天然型コロイド（血漿）、合成型コロイド（血漿））、用途別（広範囲火傷、大量血液/血漿喪失、血液量減少性ショック、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・コロイド（血漿）市場の概要 ・世界の主要地域別コロイド（血漿）市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のコロイド（血漿）市場規模2016-2021：種類別（天然型コロイド（血漿）、合成型コロイド（血漿）） ・世界のコロイド（血漿）市場予測2012-2027：種類別（天然型コロイド（血漿）、合成型コロイド（血漿）） ・世界のコロイド（血漿）市場規模2016-2021：用途別（広範囲火傷、大量血液/血漿喪失、血液量減少性ショック、その他） ・世界のコロイド（血漿）市場予測2012-2027：用途別（広範囲火傷、大量血液/血漿喪失、血液量減少性ショック、その他） ・コロイド（血漿）のアメリカ市場規模と予測2016-2021 ・コロイド（血漿）のヨーロッパ市場規模と予測2016-2021 ・コロイド（血漿）の中国市場規模と予測2016-2021 ・コロイド（血漿）の日本市場規模と予測2016-2021 ・コロイド（血漿）の東南アジア市場規模と予測2016-2021 ・コロイド（血漿）のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （CSL Behring、Baxter、Grifols、Octapharma、Kedrion、Shanghai Raas、CTBB、Hualan Bio、Rongsheng Pharmaceutical、Boya Rongsheng、B. Braun Medical、Fresenius Kabi、HOSPIRA、Axa parenterals、Fresenius Kabi(China)、CR Double-Crane、Kelun Group、Shandong Qidu Pharmaceutical、Shandong Hualu Pharmaceutical、Minsheng Pharma、Kanglepharm） ・コロイド（血漿）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・コロイド（血漿）の市場動向・機会・課題 ・調査の結論 |
Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
The global colloids (blood plasma) industry is mature. The production of synthetic colloids increase from 42.03 Million Units in 2010 to 53.43 Million Units in 2015, with an average growth rate of more than 5.42 %.
Market Analysis and Insights: Global Colloids (Blood Plasma) Market
The global Colloids (Blood Plasma) market was valued at US$ 406.7 in 2020 and will reach US$ 349.3 million by the end of 2027, growing at a CAGR of -2.5% during 2022-2027.
Global Colloids (Blood Plasma) Scope and Market Size
The global Colloids (Blood Plasma) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Colloids (Blood Plasma) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Natural Type Colloids (Blood Plasma)
Synthetic Type Colloids (Blood Plasma)
Segment by Application
Extensive Burns
Massive Blood or Plasma Loss
Hypovolemic Shock
Others
The Colloids (Blood Plasma) market is analysed and market size information is provided by regions (countries). Segment by Application, the Colloids (Blood Plasma) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
CSL Behring
Baxter
Grifols
Octapharma
Kedrion
Shanghai Raas
CTBB
Hualan Bio
Rongsheng Pharmaceutical
Boya Rongsheng
B. Braun Medical
Fresenius Kabi
HOSPIRA
Axa parenterals
Fresenius Kabi(China)
CR Double-Crane
Kelun Group
Shandong Qidu Pharmaceutical
Shandong Hualu Pharmaceutical
Minsheng Pharma
Kanglepharm
1 Colloids (Blood Plasma) Market Overview
1.1 Colloids (Blood Plasma) Product Scope
1.2 Colloids (Blood Plasma) Segment by Type
1.2.1 Global Colloids (Blood Plasma) Sales by Type (2016 & 2021 & 2027)
1.2.2 Natural Type Colloids (Blood Plasma)
1.2.3 Synthetic Type Colloids (Blood Plasma)
1.3 Colloids (Blood Plasma) Segment by Application
1.3.1 Global Colloids (Blood Plasma) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Extensive Burns
1.3.3 Massive Blood or Plasma Loss
1.3.4 Hypovolemic Shock
1.3.5 Others
1.4 Colloids (Blood Plasma) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Colloids (Blood Plasma) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Colloids (Blood Plasma) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Colloids (Blood Plasma) Price Trends (2016-2027)
2 Colloids (Blood Plasma) Estimates and Forecasts by Region
2.1 Global Colloids (Blood Plasma) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Colloids (Blood Plasma) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Colloids (Blood Plasma) Sales Market Share by Region (2016-2021)
2.2.2 Global Colloids (Blood Plasma) Revenue Market Share by Region (2016-2021)
2.3 Global Colloids (Blood Plasma) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Colloids (Blood Plasma) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Colloids (Blood Plasma) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Colloids (Blood Plasma) Estimates and Projections (2016-2027)
2.4.2 Europe Colloids (Blood Plasma) Estimates and Projections (2016-2027)
2.4.3 China Colloids (Blood Plasma) Estimates and Projections (2016-2027)
2.4.4 Japan Colloids (Blood Plasma) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Colloids (Blood Plasma) Estimates and Projections (2016-2027)
2.4.6 India Colloids (Blood Plasma) Estimates and Projections (2016-2027)
3 Global Colloids (Blood Plasma) Competition Landscape by Players
3.1 Global Top Colloids (Blood Plasma) Players by Sales (2016-2021)
3.2 Global Top Colloids (Blood Plasma) Players by Revenue (2016-2021)
3.3 Global Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Colloids (Blood Plasma) as of 2020)
3.4 Global Colloids (Blood Plasma) Average Price by Company (2016-2021)
3.5 Manufacturers Colloids (Blood Plasma) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Colloids (Blood Plasma) Market Size by Type
4.1 Global Colloids (Blood Plasma) Historic Market Review by Type (2016-2021)
4.1.1 Global Colloids (Blood Plasma) Sales Market Share by Type (2016-2021)
4.1.2 Global Colloids (Blood Plasma) Revenue Market Share by Type (2016-2021)
4.1.3 Global Colloids (Blood Plasma) Price by Type (2016-2021)
4.2 Global Colloids (Blood Plasma) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Colloids (Blood Plasma) Sales Forecast by Type (2022-2027)
4.2.2 Global Colloids (Blood Plasma) Revenue Forecast by Type (2022-2027)
4.2.3 Global Colloids (Blood Plasma) Price Forecast by Type (2022-2027)
5 Global Colloids (Blood Plasma) Market Size by Application
5.1 Global Colloids (Blood Plasma) Historic Market Review by Application (2016-2021)
5.1.1 Global Colloids (Blood Plasma) Sales Market Share by Application (2016-2021)
5.1.2 Global Colloids (Blood Plasma) Revenue Market Share by Application (2016-2021)
5.1.3 Global Colloids (Blood Plasma) Price by Application (2016-2021)
5.2 Global Colloids (Blood Plasma) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Colloids (Blood Plasma) Sales Forecast by Application (2022-2027)
5.2.2 Global Colloids (Blood Plasma) Revenue Forecast by Application (2022-2027)
5.2.3 Global Colloids (Blood Plasma) Price Forecast by Application (2022-2027)
6 North America Colloids (Blood Plasma) Market Facts & Figures
6.1 North America Colloids (Blood Plasma) Sales by Company
6.1.1 North America Colloids (Blood Plasma) Sales by Company (2016-2021)
6.1.2 North America Colloids (Blood Plasma) Revenue by Company (2016-2021)
6.2 North America Colloids (Blood Plasma) Sales Breakdown by Type
6.2.1 North America Colloids (Blood Plasma) Sales Breakdown by Type (2016-2021)
6.2.2 North America Colloids (Blood Plasma) Sales Breakdown by Type (2022-2027)
6.3 North America Colloids (Blood Plasma) Sales Breakdown by Application
6.3.1 North America Colloids (Blood Plasma) Sales Breakdown by Application (2016-2021)
6.3.2 North America Colloids (Blood Plasma) Sales Breakdown by Application (2022-2027)
7 Europe Colloids (Blood Plasma) Market Facts & Figures
7.1 Europe Colloids (Blood Plasma) Sales by Company
7.1.1 Europe Colloids (Blood Plasma) Sales by Company (2016-2021)
7.1.2 Europe Colloids (Blood Plasma) Revenue by Company (2016-2021)
7.2 Europe Colloids (Blood Plasma) Sales Breakdown by Type
7.2.1 Europe Colloids (Blood Plasma) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Colloids (Blood Plasma) Sales Breakdown by Type (2022-2027)
7.3 Europe Colloids (Blood Plasma) Sales Breakdown by Application
7.3.1 Europe 146 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 146 Sales Breakdown by Application (2022-2027)
8 China Colloids (Blood Plasma) Market Facts & Figures
8.1 China Colloids (Blood Plasma) Sales by Company
8.1.1 China Colloids (Blood Plasma) Sales by Company (2016-2021)
8.1.2 China Colloids (Blood Plasma) Revenue by Company (2016-2021)
8.2 China Colloids (Blood Plasma) Sales Breakdown by Type
8.2.1 China Colloids (Blood Plasma) Sales Breakdown by Type (2016-2021)
8.2.2 China Colloids (Blood Plasma) Sales Breakdown by Type (2022-2027)
8.3 China Colloids (Blood Plasma) Sales Breakdown by Application
8.3.1 China 314 Sales Breakdown by Application (2016-2021)
8.3.2 China 314 Sales Breakdown by Application (2022-2027)
9 Japan Colloids (Blood Plasma) Market Facts & Figures
9.1 Japan Colloids (Blood Plasma) Sales by Company
9.1.1 Japan Colloids (Blood Plasma) Sales by Company (2016-2021)
9.1.2 Japan Colloids (Blood Plasma) Revenue by Company (2016-2021)
9.2 Japan Colloids (Blood Plasma) Sales Breakdown by Type
9.2.1 Japan Colloids (Blood Plasma) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Colloids (Blood Plasma) Sales Breakdown by Type (2022-2027)
9.3 Japan Colloids (Blood Plasma) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Colloids (Blood Plasma) Market Facts & Figures
10.1 Southeast Asia Colloids (Blood Plasma) Sales by Company
10.1.1 Southeast Asia Colloids (Blood Plasma) Sales by Company (2016-2021)
10.1.2 Southeast Asia Colloids (Blood Plasma) Revenue by Company (2016-2021)
10.2 Southeast Asia Colloids (Blood Plasma) Sales Breakdown by Type
10.2.1 Southeast Asia Colloids (Blood Plasma) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Colloids (Blood Plasma) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Colloids (Blood Plasma) Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)
11 India Colloids (Blood Plasma) Market Facts & Figures
11.1 India Colloids (Blood Plasma) Sales by Company
11.1.1 India Colloids (Blood Plasma) Sales by Company (2016-2021)
11.1.2 India Colloids (Blood Plasma) Revenue by Company (2016-2021)
11.2 India Colloids (Blood Plasma) Sales Breakdown by Type
11.2.1 India Colloids (Blood Plasma) Sales Breakdown by Type (2016-2021)
11.2.2 India Colloids (Blood Plasma) Sales Breakdown by Type (2022-2027)
11.3 India Colloids (Blood Plasma) Sales Breakdown by Application
11.3.1 India Colloids (Blood Plasma) Sales Breakdown by Application (2016-2021)
11.3.2 India Colloids (Blood Plasma) Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Colloids (Blood Plasma) Business
12.1 CSL Behring
12.1.1 CSL Behring Corporation Information
12.1.2 CSL Behring Business Overview
12.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CSL Behring Colloids (Blood Plasma) Products Offered
12.1.5 CSL Behring Recent Development
12.2 Baxter
12.2.1 Baxter Corporation Information
12.2.2 Baxter Business Overview
12.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Baxter Colloids (Blood Plasma) Products Offered
12.2.5 Baxter Recent Development
12.3 Grifols
12.3.1 Grifols Corporation Information
12.3.2 Grifols Business Overview
12.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Grifols Colloids (Blood Plasma) Products Offered
12.3.5 Grifols Recent Development
12.4 Octapharma
12.4.1 Octapharma Corporation Information
12.4.2 Octapharma Business Overview
12.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Octapharma Colloids (Blood Plasma) Products Offered
12.4.5 Octapharma Recent Development
12.5 Kedrion
12.5.1 Kedrion Corporation Information
12.5.2 Kedrion Business Overview
12.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Kedrion Colloids (Blood Plasma) Products Offered
12.5.5 Kedrion Recent Development
12.6 Shanghai Raas
12.6.1 Shanghai Raas Corporation Information
12.6.2 Shanghai Raas Business Overview
12.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Shanghai Raas Colloids (Blood Plasma) Products Offered
12.6.5 Shanghai Raas Recent Development
12.7 CTBB
12.7.1 CTBB Corporation Information
12.7.2 CTBB Business Overview
12.7.3 CTBB Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 CTBB Colloids (Blood Plasma) Products Offered
12.7.5 CTBB Recent Development
12.8 Hualan Bio
12.8.1 Hualan Bio Corporation Information
12.8.2 Hualan Bio Business Overview
12.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hualan Bio Colloids (Blood Plasma) Products Offered
12.8.5 Hualan Bio Recent Development
12.9 Rongsheng Pharmaceutical
12.9.1 Rongsheng Pharmaceutical Corporation Information
12.9.2 Rongsheng Pharmaceutical Business Overview
12.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Products Offered
12.9.5 Rongsheng Pharmaceutical Recent Development
12.10 Boya Rongsheng
12.10.1 Boya Rongsheng Corporation Information
12.10.2 Boya Rongsheng Business Overview
12.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Boya Rongsheng Colloids (Blood Plasma) Products Offered
12.10.5 Boya Rongsheng Recent Development
12.11 B. Braun Medical
12.11.1 B. Braun Medical Corporation Information
12.11.2 B. Braun Medical Business Overview
12.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 B. Braun Medical Colloids (Blood Plasma) Products Offered
12.11.5 B. Braun Medical Recent Development
12.12 Fresenius Kabi
12.12.1 Fresenius Kabi Corporation Information
12.12.2 Fresenius Kabi Business Overview
12.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Fresenius Kabi Colloids (Blood Plasma) Products Offered
12.12.5 Fresenius Kabi Recent Development
12.13 HOSPIRA
12.13.1 HOSPIRA Corporation Information
12.13.2 HOSPIRA Business Overview
12.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 HOSPIRA Colloids (Blood Plasma) Products Offered
12.13.5 HOSPIRA Recent Development
12.14 Axa parenterals
12.14.1 Axa parenterals Corporation Information
12.14.2 Axa parenterals Business Overview
12.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Axa parenterals Colloids (Blood Plasma) Products Offered
12.14.5 Axa parenterals Recent Development
12.15 Fresenius Kabi(China)
12.15.1 Fresenius Kabi(China) Corporation Information
12.15.2 Fresenius Kabi(China) Business Overview
12.15.3 Fresenius Kabi(China) Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Fresenius Kabi(China) Colloids (Blood Plasma) Products Offered
12.15.5 Fresenius Kabi(China) Recent Development
12.16 CR Double-Crane
12.16.1 CR Double-Crane Corporation Information
12.16.2 CR Double-Crane Business Overview
12.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.16.4 CR Double-Crane Colloids (Blood Plasma) Products Offered
12.16.5 CR Double-Crane Recent Development
12.17 Kelun Group
12.17.1 Kelun Group Corporation Information
12.17.2 Kelun Group Business Overview
12.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Kelun Group Colloids (Blood Plasma) Products Offered
12.17.5 Kelun Group Recent Development
12.18 Shandong Qidu Pharmaceutical
12.18.1 Shandong Qidu Pharmaceutical Corporation Information
12.18.2 Shandong Qidu Pharmaceutical Business Overview
12.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Products Offered
12.18.5 Shandong Qidu Pharmaceutical Recent Development
12.19 Shandong Hualu Pharmaceutical
12.19.1 Shandong Hualu Pharmaceutical Corporation Information
12.19.2 Shandong Hualu Pharmaceutical Business Overview
12.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Products Offered
12.19.5 Shandong Hualu Pharmaceutical Recent Development
12.20 Minsheng Pharma
12.20.1 Minsheng Pharma Corporation Information
12.20.2 Minsheng Pharma Business Overview
12.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Minsheng Pharma Colloids (Blood Plasma) Products Offered
12.20.5 Minsheng Pharma Recent Development
12.21 Kanglepharm
12.21.1 Kanglepharm Corporation Information
12.21.2 Kanglepharm Business Overview
12.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Kanglepharm Colloids (Blood Plasma) Products Offered
12.21.5 Kanglepharm Recent Development
13 Colloids (Blood Plasma) Manufacturing Cost Analysis
13.1 Colloids (Blood Plasma) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Colloids (Blood Plasma)
13.4 Colloids (Blood Plasma) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Colloids (Blood Plasma) Distributors List
14.3 Colloids (Blood Plasma) Customers
15 Market Dynamics
15.1 Colloids (Blood Plasma) Market Trends
15.2 Colloids (Blood Plasma) Drivers
15.3 Colloids (Blood Plasma) Market Challenges
15.4 Colloids (Blood Plasma) Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Colloids (Blood Plasma) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Colloids (Blood Plasma) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Colloids (Blood Plasma) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Colloids (Blood Plasma) Sales (MT) by Region (2016-2021)
Table 5. Global Colloids (Blood Plasma) Sales Market Share by Region (2016-2021)
Table 6. Global Colloids (Blood Plasma) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Colloids (Blood Plasma) Revenue Share by Region (2016-2021)
Table 8. Global Colloids (Blood Plasma) Sales (MT) Forecast by Region (2022-2027)
Table 9. Global Colloids (Blood Plasma) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Colloids (Blood Plasma) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Colloids (Blood Plasma) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Colloids (Blood Plasma) Sales (MT) of Key Companies (2016-2021)
Table 13. Global Colloids (Blood Plasma) Sales Share by Company (2016-2021)
Table 14. Global Colloids (Blood Plasma) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Colloids (Blood Plasma) Revenue Share by Company (2016-2021)
Table 16. Global Colloids (Blood Plasma) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colloids (Blood Plasma) as of 2020)
Table 17. Global Colloids (Blood Plasma) Average Price (USD/Kg) of Key Company (2016-2021)
Table 18. Manufacturers Colloids (Blood Plasma) Manufacturing Sites and Area Served
Table 19. Manufacturers Colloids (Blood Plasma) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Colloids (Blood Plasma) Sales (MT) by Type (2016-2021)
Table 22. Global Colloids (Blood Plasma) Sales Share by Type (2016-2021)
Table 23. Global Colloids (Blood Plasma) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Colloids (Blood Plasma) Price (USD/Kg) by Type (2016-2021)
Table 25. Global Colloids (Blood Plasma) Sales Share by Type (2022-2027)
Table 26. Global Colloids (Blood Plasma) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Colloids (Blood Plasma) Revenue Share by Type (2022-2027)
Table 28. Global Colloids (Blood Plasma) Price (USD/Kg) by Type (2022-2027)
Table 29. Global Colloids (Blood Plasma) Sales (MT) by Application (2016-2021)
Table 30. Global Colloids (Blood Plasma) Sales Share by Application (2016-2021)
Table 31. Global Colloids (Blood Plasma) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Colloids (Blood Plasma) Price (USD/Kg) by Application (2016-2021)
Table 33. Global Colloids (Blood Plasma) Sales (MT) by Application (2022-2027)
Table 34. Global Colloids (Blood Plasma) Sales Share by Application (2022-2027)
Table 35. Global Colloids (Blood Plasma) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Colloids (Blood Plasma) Revenue Share by Application (2022-2027)
Table 37. Global Colloids (Blood Plasma) Price (USD/Kg) by Application (2022-2027)
Table 38. North America Colloids (Blood Plasma) Sales (MT) by Company (2016-2021)
Table 39. North America Colloids (Blood Plasma) Sales Market Share by Company (2016-2021)
Table 40. North America Colloids (Blood Plasma) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Colloids (Blood Plasma) Revenue Market Share by Company (2016-2021)
Table 42. North America Colloids (Blood Plasma) Sales by Type (2016-2021) & (MT)
Table 43. North America Colloids (Blood Plasma) Sales Market Share by Type (2016-2021)
Table 44. North America Colloids (Blood Plasma) Sales by Type (2022-2027) & (MT)
Table 45. North America Colloids (Blood Plasma) Sales Market Share by Type (2022-2027)
Table 46. North America Colloids (Blood Plasma) Sales by Application (2016-2021) & (MT)
Table 47. North America Colloids (Blood Plasma) Sales Market Share by Application (2016-2021)
Table 48. North America Colloids (Blood Plasma) Sales by Application (2022-2027) & (MT)
Table 49. North America Colloids (Blood Plasma) Sales Market Share by Application (2022-2027)
Table 50. Europe Colloids (Blood Plasma) Sales (MT) by Company (2016-2021)
Table 51. Europe Colloids (Blood Plasma) Sales Market Share by Company (2016-2021)
Table 52. Europe Colloids (Blood Plasma) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Colloids (Blood Plasma) Revenue Market Share by Company (2016-2021)
Table 54. Europe Colloids (Blood Plasma) Sales by Type (2016-2021) & (MT)
Table 55. Europe Colloids (Blood Plasma) Sales Market Share by Type (2016-2021)
Table 56. Europe Colloids (Blood Plasma) Sales by Type (2022-2027) & (MT)
Table 57. Europe Colloids (Blood Plasma) Sales Market Share by Type (2022-2027)
Table 58. Europe Colloids (Blood Plasma) Sales by Application (2016-2021) & (MT)
Table 59. Europe Colloids (Blood Plasma) Sales Market Share by Application (2016-2021)
Table 60. Europe Colloids (Blood Plasma) Sales by Application (2022-2027) & (MT)
Table 61. Europe Colloids (Blood Plasma) Sales Market Share by Application (2022-2027)
Table 62. China Colloids (Blood Plasma) Sales (MT) by Company (2016-2021)
Table 63. China Colloids (Blood Plasma) Sales Market Share by Company (2016-2021)
Table 64. China Colloids (Blood Plasma) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Colloids (Blood Plasma) Revenue Market Share by Company (2016-2021)
Table 66. China Colloids (Blood Plasma) Sales by Type (2016-2021) & (MT)
Table 67. China Colloids (Blood Plasma) Sales Market Share by Type (2016-2021)
Table 68. China Colloids (Blood Plasma) Sales by Type (2022-2027) & (MT)
Table 69. China Colloids (Blood Plasma) Sales Market Share by Type (2022-2027)
Table 70. China Colloids (Blood Plasma) Sales by Application (2016-2021) & (MT)
Table 71. China Colloids (Blood Plasma) Sales Market Share by Application (2016-2021)
Table 72. China Colloids (Blood Plasma) Sales by Application (2022-2027) & (MT)
Table 73. China Colloids (Blood Plasma) Sales Market Share by Application (2022-2027)
Table 74. Japan Colloids (Blood Plasma) Sales (MT) by Company (2016-2021)
Table 75. Japan Colloids (Blood Plasma) Sales Market Share by Company (2016-2021)
Table 76. Japan Colloids (Blood Plasma) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Colloids (Blood Plasma) Revenue Market Share by Company (2016-2021)
Table 78. Japan Colloids (Blood Plasma) Sales by Type (2016-2021) & (MT)
Table 79. Japan Colloids (Blood Plasma) Sales Market Share by Type (2016-2021)
Table 80. Japan Colloids (Blood Plasma) Sales by Type (2022-2027) & (MT)
Table 81. Japan Colloids (Blood Plasma) Sales Market Share by Type (2022-2027)
Table 82. Japan Colloids (Blood Plasma) Sales by Application (2016-2021) & (MT)
Table 83. Japan Colloids (Blood Plasma) Sales Market Share by Application (2016-2021)
Table 84. Japan Colloids (Blood Plasma) Sales by Application (2022-2027) & (MT)
Table 85. Japan Colloids (Blood Plasma) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Colloids (Blood Plasma) Sales (MT) by Company (2016-2021)
Table 87. Southeast Asia Colloids (Blood Plasma) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Colloids (Blood Plasma) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Colloids (Blood Plasma) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Colloids (Blood Plasma) Sales by Type (2016-2021) & (MT)
Table 91. Southeast Asia Colloids (Blood Plasma) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Colloids (Blood Plasma) Sales by Type (2022-2027) & (MT)
Table 93. Southeast Asia Colloids (Blood Plasma) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Colloids (Blood Plasma) Sales by Application (2016-2021) & (MT)
Table 95. Southeast Asia Colloids (Blood Plasma) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Colloids (Blood Plasma) Sales by Application (2022-2027) & (MT)
Table 97. Southeast Asia Colloids (Blood Plasma) Sales Market Share by Application (2022-2027)
Table 98. India Colloids (Blood Plasma) Sales (MT) by Company (2016-2021)
Table 99. India Colloids (Blood Plasma) Sales Market Share by Company (2016-2021)
Table 100. India Colloids (Blood Plasma) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Colloids (Blood Plasma) Revenue Market Share by Company (2016-2021)
Table 102. India Colloids (Blood Plasma) Sales by Type (2016-2021) & (MT)
Table 103. India Colloids (Blood Plasma) Sales Market Share by Type (2016-2021)
Table 104. India Colloids (Blood Plasma) Sales by Type (2022-2027) & (MT)
Table 105. India Colloids (Blood Plasma) Sales Market Share by Type (2022-2027)
Table 106. India Colloids (Blood Plasma) Sales by Application (2016-2021) & (MT)
Table 107. India Colloids (Blood Plasma) Sales Market Share by Application (2016-2021)
Table 108. India Colloids (Blood Plasma) Sales by Application (2022-2027) & (MT)
Table 109. India Colloids (Blood Plasma) Sales Market Share by Application (2022-2027)
Table 110. CSL Behring Corporation Information
Table 111. CSL Behring Description and Business Overview
Table 112. CSL Behring Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 113. CSL Behring Colloids (Blood Plasma) Product
Table 114. CSL Behring Recent Development
Table 115. Baxter Corporation Information
Table 116. Baxter Description and Business Overview
Table 117. Baxter Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 118. Baxter Colloids (Blood Plasma) Product
Table 119. Baxter Recent Development
Table 120. Grifols Corporation Information
Table 121. Grifols Description and Business Overview
Table 122. Grifols Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 123. Grifols Colloids (Blood Plasma) Product
Table 124. Grifols Recent Development
Table 125. Octapharma Corporation Information
Table 126. Octapharma Description and Business Overview
Table 127. Octapharma Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 128. Octapharma Colloids (Blood Plasma) Product
Table 129. Octapharma Recent Development
Table 130. Kedrion Corporation Information
Table 131. Kedrion Description and Business Overview
Table 132. Kedrion Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 133. Kedrion Colloids (Blood Plasma) Product
Table 134. Kedrion Recent Development
Table 135. Shanghai Raas Corporation Information
Table 136. Shanghai Raas Description and Business Overview
Table 137. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 138. Shanghai Raas Colloids (Blood Plasma) Product
Table 139. Shanghai Raas Recent Development
Table 140. CTBB Corporation Information
Table 141. CTBB Description and Business Overview
Table 142. CTBB Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 143. CTBB Colloids (Blood Plasma) Product
Table 144. CTBB Recent Development
Table 145. Hualan Bio Corporation Information
Table 146. Hualan Bio Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 147. Hualan Bio Description and Business Overview
Table 148. Hualan Bio Colloids (Blood Plasma) Product
Table 149. Hualan Bio Recent Development
Table 150. Rongsheng Pharmaceutical Corporation Information
Table 151. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 152. Rongsheng Pharmaceutical Description and Business Overview
Table 153. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product
Table 154. Rongsheng Pharmaceutical Recent Development
Table 155. Boya Rongsheng Corporation Information
Table 156. Boya Rongsheng Description and Business Overview
Table 157. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 158. Boya Rongsheng Colloids (Blood Plasma) Product
Table 159. Boya Rongsheng Recent Development
Table 160. B. Braun Medical Corporation Information
Table 161. B. Braun Medical Description and Business Overview
Table 162. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 163. B. Braun Medical Colloids (Blood Plasma) Product
Table 164. B. Braun Medical Recent Development
Table 165. Fresenius Kabi Corporation Information
Table 166. Fresenius Kabi Description and Business Overview
Table 167. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 168. Fresenius Kabi Colloids (Blood Plasma) Product
Table 169. Fresenius Kabi Recent Development
Table 170. HOSPIRA Corporation Information
Table 171. HOSPIRA Description and Business Overview
Table 172. HOSPIRA Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 173. HOSPIRA Colloids (Blood Plasma) Product
Table 174. HOSPIRA Recent Development
Table 175. Axa parenterals Corporation Information
Table 176. Axa parenterals Description and Business Overview
Table 177. Axa parenterals Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 178. Axa parenterals Colloids (Blood Plasma) Product
Table 179. Axa parenterals Recent Development
Table 180. Fresenius Kabi(China) Corporation Information
Table 181. Fresenius Kabi(China) Description and Business Overview
Table 182. Fresenius Kabi(China) Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 183. Fresenius Kabi(China) Colloids (Blood Plasma) Product
Table 184. Fresenius Kabi(China) Recent Development
Table 185. CR Double-Crane Corporation Information
Table 186. CR Double-Crane Description and Business Overview
Table 187. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 188. CR Double-Crane Colloids (Blood Plasma) Product
Table 189. CR Double-Crane Recent Development
Table 190. Kelun Group Corporation Information
Table 191. Kelun Group Description and Business Overview
Table 192. Kelun Group Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 193. Kelun Group Colloids (Blood Plasma) Product
Table 194. Kelun Group Recent Development
Table 195. Shandong Qidu Pharmaceutical Corporation Information
Table 196. Shandong Qidu Pharmaceutical Description and Business Overview
Table 197. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 198. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product
Table 199. Shandong Qidu Pharmaceutical Recent Development
Table 200. Shandong Hualu Pharmaceutical Corporation Information
Table 201. Shandong Hualu Pharmaceutical Description and Business Overview
Table 202. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 203. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product
Table 204. Shandong Hualu Pharmaceutical Recent Development
Table 205. Minsheng Pharma Corporation Information
Table 206. Minsheng Pharma Description and Business Overview
Table 207. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 208. Minsheng Pharma Colloids (Blood Plasma) Product
Table 209. Minsheng Pharma Recent Development
Table 210. Kanglepharm Corporation Information
Table 211. Kanglepharm Description and Business Overview
Table 212. Kanglepharm Colloids (Blood Plasma) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2016-2021)
Table 213. Kanglepharm Colloids (Blood Plasma) Product
Table 214. Kanglepharm Recent Development
Table 215. Production Base and Market Concentration Rate of Raw Material
Table 216. Key Suppliers of Raw Materials
Table 217. Colloids (Blood Plasma) Distributors List
Table 218. Colloids (Blood Plasma) Customers List
Table 219. Colloids (Blood Plasma) Market Trends
Table 220. Colloids (Blood Plasma) Market Drivers
Table 221. Colloids (Blood Plasma) Market Challenges
Table 222. Colloids (Blood Plasma) Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Colloids (Blood Plasma) Product Picture
Figure 2. Global Colloids (Blood Plasma) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Colloids (Blood Plasma) Sales Market Share by Application in 2021 & 2027
Figure 6. Extensive Burns Examples
Figure 7. Massive Blood or Plasma Loss Examples
Figure 8. Hypovolemic Shock Examples
Figure 9. Others Examples
Figure 10. Global Colloids (Blood Plasma) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Colloids (Blood Plasma) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Colloids (Blood Plasma) Sales (MT) Growth Rate (2016-2027)
Figure 13. Global Colloids (Blood Plasma) Price Trends Growth Rate (2016-2027) (USD/Kg)
Figure 14. Global Colloids (Blood Plasma) Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Colloids (Blood Plasma) Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Colloids (Blood Plasma) Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Colloids (Blood Plasma) Sales (MT) Growth Rate (2016-2027)
Figure 18. Europe Colloids (Blood Plasma) Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Colloids (Blood Plasma) Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Colloids (Blood Plasma) Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Colloids (Blood Plasma) Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Colloids (Blood Plasma) Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Colloids (Blood Plasma) Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Colloids (Blood Plasma) Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Colloids (Blood Plasma) Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Colloids (Blood Plasma) Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Colloids (Blood Plasma) Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Colloids (Blood Plasma) Players Market Share by Revenue in Colloids (Blood Plasma): 2016 & 2020
Figure 29. Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Colloids (Blood Plasma) Revenue Share by Type (2016-2021)
Figure 31. Global Colloids (Blood Plasma) Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Colloids (Blood Plasma) Revenue Share by Application (2016-2021)
Figure 33. Global Colloids (Blood Plasma) Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Colloids (Blood Plasma) Sales Market Share by Type in 2020
Figure 35. North America Colloids (Blood Plasma) Sales Market Share by Application in 2020
Figure 36. Europe Colloids (Blood Plasma) Sales Market Share by Type in 2020
Figure 37. Europe Colloids (Blood Plasma) Sales Market Share by Application in 2020
Figure 38. China Colloids (Blood Plasma) Sales Market Share by Type in 2020
Figure 39. China Colloids (Blood Plasma) Sales Market Share by Application in 2020
Figure 40. Japan Colloids (Blood Plasma) Sales Market Share by Type in 2020
Figure 41. Japan Colloids (Blood Plasma) Sales Market Share by Application in 2020
Figure 42. Southeast Asia Colloids (Blood Plasma) Sales Market Share by Type in 2020
Figure 43. Southeast Asia Colloids (Blood Plasma) Sales Market Share by Application in 2020
Figure 44. India Colloids (Blood Plasma) Sales Market Share by Type in 2020
Figure 45. India Colloids (Blood Plasma) Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Colloids (Blood Plasma)
Figure 48. Manufacturing Process Analysis of Colloids (Blood Plasma)
Figure 49. Colloids (Blood Plasma) Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
世界の血漿誘導体市場規模・現状・予測（2021年-2027年） Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and bloo…- 血漿分画のグローバル市場調査 2019年 The global Blood Plasma Fractionation market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Blood Plasma Fractionation volume and value at global level, regional level and company level. From a global per…
- 世界の動物血漿＆誘導体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Animal Blood Plasma and Derivatives Market The global Animal Blood Plasma and Derivatives market size is projected to reach US$ 1343.1 million by 2027, from US$ 981.1 million in 2020, at a CAGR of 4.5% during 2021-2027. With industry-standard accuracy in analysis…
- 血漿分画装置のグローバル市場調査 2019年 The global Blood Plasma Fractionators market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Blood Plasma Fractionators volume and value at global level, regional level and company level. From a global per…
- 血漿採血管のグローバル市場調査 2019年 The global Plasma Blood Collection Tube market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Plasma Blood Collection Tube volume and value at global level, regional level and company level. From a global…